International Study of a Smartphone-Based Symptom Assessment (OurBrainBank) for Subjects with Glioblastomas

November 2020 Vol 11, No 11
Jessica Morris
OurBrainBank,
Brooklyn, NY
Bruce Hellman
OurBrainBank,
Brooklyn, NY
Kelli Duprey
OurBrainBank,
Brooklyn, NY
Jacob Ellen
OurBrainBank,
Brooklyn, NY
Lakshmi Nayak
OurBrainBank,
Brooklyn, NY
Fabio Iwamoto
OurBrainBank,
Brooklyn, NY
Florien Boele
OurBrainBank,
Brooklyn, NY

Background: Self-reports from patients done monthly or every few months in the doctor’s office have several limitations, including poor recall, underreporting or overreporting of events, among other biases.

Methods: We developed a glioblastoma-specific app (OurBrainBank) using a platform designed by uMotif that was previously used in other conditions but has been customized for glioblastoma. All data are sent to a HIPAA- compliant database. The subject can view or export their own data as well and create data reports to their medical team. Inclusion criteria included age 18 years or older, diagnosis of glioblastoma, English-speaking subject, and availability of a smartphone or tablet. After electronic informed consent, patients completed baseline questionnaires about their treatment and validated surveys (EORTC-QLQ, EORTC-BN20). Certain parameters, such as sleep quality, exercise, mood, and fatigue, were captured for all patients. In addition, patients picked 6 additional symptoms most relevant to their clinical condition.

Results: Since the study was IRB-approved and the app made available free of charge on app stores, there have been 615 individual patients who registered on this app. In addition, we launched in the United Kingdom in December 2019, and 45 patients have been accrued there. Recruitment has relied heavily on social media and patient-run online support groups. The most commonly tracked symptoms were exercise, fatigue, mood, sleep quality, appetite, memory, and concentration. Patients were alerted to capture symptoms at least weekly, and more than 13,000 data points were captured. Most patients found symptom tracking useful (average rating of 7 on 0-10 scale).

Conclusion: At this stage, OurBrainBank has shown that it can efficiently collect glioblastoma patients’ symptoms. In the next steps, we plan to collect passive data from smartphones and other device trackers. Additionally, OurBrainBank will enable patients to donate their medical records to a national and international database.

Objectives: The goal over the next few years is to create an unprecedented database of high quality and granularity with tens of thousands of deidentified glioblastoma patients, with open access to qualified academic researchers. In addition, this powerful “real-world experience” database will be useful for pharma/biotech companies.

Related Articles
Our Health History Is in the Stories We Tell Within Black and Brown Families
Maimah Karmo
|
May 2023 Vol 14, No 5

With National Black Family Cancer Awareness Week (June 15-21, 2023) on the horizon, it is paramount to acknowledge the pivotal role that nurse navigators play in educating and empowering patients and their loved ones—to include fostering candid and transparent conversations about family health history, knowing our bodies, risk reduction, and proactive cancer screenings. As a breast cancer survivor and founder of the Tigerlily Foundation, I am a testament to the profound, lifesaving impact of these conversations. My mother was a nurse, and I often say that she gave me life and saved my life. Here’s how.

Assessment of Side Effects (SEs) Impacting Quality of Life (QOL) in Patients (Pts) Undergoing Treatment (tx) for Advanced Breast Cancer (ABC) in Clinical Practice: A Real-World (RW) Multicountry Survey
November 2022 Vol 13, No 11
To examine how SEs impacting QOL in pts with ABC are perceived.
Intracranial Activity of Tepotinib in Patients with MET Exon 14 (METex14) Skipping Non–Small-Cell Lung Cancer (NSCLC) Enrolled in VISION
November 2022 Vol 13, No 11
To provide analysis of the intracranial activity of tepotinib in patients with METex14 skipping NSCLC with BM from the VISION study to aid oncology nurse navigators who manage this population of patients.
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country